… Therefore, we tested whether administration of multipotent mesenchymal stem cells (MSC)
to anesthetized rats with ischemia-reperfusion-induced ARF (40-min bilateral renal pedicle …

… location of labeled mesenchymal stem cells, and their early … of administered mesenchymal
stem cells into renal cells, a … Whether the prolonged presence of mesenchymal stem cells …

… , culture-expanded allogeneic mesenchymal stem cells. Their administration into the suprarenal
… Infused mesenchymal stem cells, recruited to renal sites of injury, did not significantly …

… Administered mesenchymal stem cells protect against ischemic acute renal failure
through differentiation-independent mechanisms. Am J Physiol Renal Physiol (2005) 289(1):F31–42. …

… of administered mesenchymal stem cells (MSCs) in vivo. MSCs were transfected with a
luciferase/neomycin phosphotransferase construct (luc/neo-MSC). Bioluminescence of these …

… from several laboratories shows that administration of adult mesenchymal stem cells (MSCs) …
administered to open-heart surgery patients who were at high risk of postoperative AKI. …

… We investigated the kinetics of human mesenchymal stem cells (MSCs) after intravascular
administration into SCID mouse cremaster vasculature by intravital microscopy. MSCs were …

… + cells increased within 5 days, leading to a dramatic regeneration of the somatosensory cortex
and hippocampus at 18 days after intranasal MSC administration… MSC administration is a …

… Transplantation of human mesenchymal stem cells has been … of autologous human
mesenchymal stem cells expanded in … We administered 0.6 to 1.6 × 10 8 cells to each patient over …

… Intravenously administered mesenchymal stem cell (MSCs) inhibit many of these … A critical
issue solved by the intravenous administration of stem cells arises from the improbability that …